You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 9,499,619


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,499,619
Title:Polyclonal bispecific antibody compositions and method of use
Abstract: The invention relates to compositions and methods for treating a host infected with a pathogen. The composition comprising a population of polyclonal bispecific binding molecules that can target and eliminate a host cell infected with the pathogen. Methods for activating and arming cytotoxic immune cells with the composition for use in treating a patient infected with a pathogen are also provided.
Inventor(s): Lum; Lawrence G. (Harrison Township, MI), Huang; Manley (Palo Alto, CA)
Assignee: TRANSTARGET, INC. (Burlingame, CA) WAYNE STATE UNIVERSITY (Detroit, MI)
Application Number:14/637,194
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive Analysis of the Claims and Patent Landscape for United States Patent 9,499,619

Introduction

Patent 9,499,619, like any other patent, is a complex document that grants exclusive rights to its owner for a specific invention. To understand its significance and the broader patent landscape, it is crucial to delve into the various components of the patent, the requirements for patentability, and the enforcement mechanisms.

Understanding the Patent Structure

A patent typically includes several key sections:

  • Title and Abstract: These provide a brief overview of the invention.
  • Drawings: Illustrations that help explain the invention.
  • Specification: A detailed textual description of the invention, including its background, summary, and detailed description[1].
  • Claims: These define the legal boundaries of the patent owner’s exclusive rights and are crucial for determining the scope of the patent[1].

Patentability Requirements

For a patent to be granted, the invention must meet several stringent requirements:

Patentable Subject Matter

The invention must fall within one of the statutorily defined categories of patent-eligible subject matter, such as processes, machines, manufactures, or compositions of matter[1].

Definiteness

The patent claims must be sufficiently clear and definite to inform the public of the scope of the invention[1].

Written Description

The specification must adequately describe the invention, ensuring that it is fully disclosed[1].

Enablement

The specification must enable a person skilled in the relevant technology to make and use the invention[1].

Novelty

The invention must be new and not the same as something known in the prior art at the time of the invention[1][2].

Nonobviousness

The invention must not be an obvious extension of the prior art; it must be significantly different and innovative[1][2].

Prior Art Search and Analysis

A critical step in determining patentability is the prior art search. This involves reviewing existing patents and publications to ensure the invention is novel and nonobvious. For Patent 9,499,619, this would have included:

  • Prior Art Search: Identifying relevant prior art to compare against the claims of the patent.
  • Patentability Analysis: Analyzing the claims against the prior art to determine if they are novel and nonobvious[2].

Claims Analysis

The claims of Patent 9,499,619 would need to be scrutinized to ensure they meet the patentability requirements. Here are some key aspects to consider:

Claim Scope

The claims define the metes and bounds of the patent right. They must be clear, concise, and not overly broad or vague[1].

Novelty and Nonobviousness

Each claim must be compared against prior art to ensure it is novel and nonobvious. Any overlap with prior art could invalidate the claim[2].

Enablement and Written Description

The specification must support the claims by providing enough detail to enable a person skilled in the art to make and use the invention[1].

Enforcement and Litigation

Patent enforcement is crucial for protecting the exclusive rights granted by the patent.

Patent Infringement

This includes direct infringement, infringement under the doctrine of equivalents, induced infringement, and contributory infringement. Litigation can occur in federal district court or before the International Trade Commission (ITC)[1].

Patent Assertion Entities (PAEs)

PAEs, also known as "patent trolls," can significantly impact the patent landscape. They often acquire patents and assert them against alleged infringers, either through licensing agreements or litigation. The FTC has identified two main types of PAEs: Portfolio PAEs and Litigation PAEs, each with different strategies for generating revenue[3].

The Role of AI in Patent Applications

With the increasing use of AI tools in patent drafting, it is essential to ensure that any contributions made by AI are disclosed to the USPTO. This includes assessing whether the contributions made by natural persons rise to the level of inventorship and verifying the accuracy of factual assertions[5].

Valuation of Patents

The value of a patent, such as 9,499,619, can be determined using various methods:

  • Cost Approach: The cost of developing the patent.
  • Income Approach: The present value of future benefits provided by the patent.
  • Market Approach: The price a willing buyer would pay for a similar patent[4].

Impact on Market Domination

A patent like 9,499,619 can be a powerful tool for market domination if it covers a significant innovation. Here are some ways it can impact the market:

Exclusive Rights

The patent grants the owner exclusive rights to make, use, import, sell, or offer for sale the invention, allowing them to control the market for the patented technology[1].

Licensing and Revenue

The owner can license the patent to other companies, generating significant revenue. This is particularly true for Portfolio PAEs, which negotiate licenses covering large portfolios of patents[3].

Innovation and Competition

By protecting innovative technologies, patents can encourage further innovation and competition. However, they can also stifle competition if they are used to block other innovations or if they fall into the hands of PAEs that assert them aggressively[3].

Key Takeaways

  • Patent Structure: A patent includes a title, abstract, drawings, specification, and claims.
  • Patentability Requirements: Inventions must meet requirements for patentable subject matter, definiteness, written description, enablement, novelty, and nonobviousness.
  • Prior Art Search: Essential for determining novelty and nonobviousness.
  • Enforcement: Patents can be enforced through litigation in federal district court or before the ITC.
  • AI Contributions: Must be disclosed to the USPTO to ensure compliance with patent laws.
  • Valuation: Patents can be valued using cost, income, and market approaches.
  • Market Impact: Patents can grant exclusive rights, generate revenue through licensing, and influence innovation and competition.

FAQs

Q: What are the key components of a patent?

A: The key components include the title, abstract, drawings, specification, and claims.

Q: Why is a prior art search important?

A: It helps determine if the invention is novel and nonobvious, which are critical requirements for patentability.

Q: How do Patent Assertion Entities (PAEs) impact the patent landscape?

A: PAEs can significantly impact the landscape by acquiring and asserting patents, often through litigation or licensing agreements, which can generate substantial revenue but also stifle innovation.

Q: What role does AI play in patent applications?

A: AI can assist in drafting patent applications, but any contributions made by AI must be disclosed to the USPTO to ensure compliance with patent laws.

Q: How is the value of a patent determined?

A: The value can be determined using the cost approach (development cost), income approach (future benefits), or market approach (price a willing buyer would pay).

Sources

  1. Congressional Research Service, "Patent Law: A Handbook for Congress," September 16, 2020.
  2. InterSECT Job Simulations, "IP: Patentability Analysis."
  3. Federal Trade Commission, "Patent Assertion Entity Activity: An FTC Study."
  4. Perpetual Motion Patents, "The Value of a Patent."
  5. Buchanan Ingersoll & Rooney PC, "U.S. Patent Office Issues Additional Guidance on Use of AI Tools," April 15, 2024.

More… ↓

⤷  Subscribe

Details for Patent 9,499,619

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Kamada Ltd. CYTOGAM cytomegalovirus immune globulin intravenous (human) Injection 103189 April 17, 1990 ⤷  Subscribe 2029-11-06
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.